

| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 2mg | 360 pills | £0.62 | £222.55 Best Price | |
| 2mg | 270 pills | £0.67 | £182.09 | |
| 2mg | 180 pills | £0.73 | £131.50 | |
| 2mg | 120 pills | £0.79 | £94.41 | |
| 2mg | 90 pills | £0.98 | £87.67 | |
| 2mg | 60 pills | £1.01 | £60.69 | |
| 2mg | 30 pills | £1.16 | £34.83 | |
| 4mg | 360 pills | £0.63 | £227.05 Popular | |
| 4mg | 270 pills | £0.66 | £178.71 | |
| 4mg | 180 pills | £0.72 | £129.26 | |
| 4mg | 120 pills | £0.78 | £93.29 | |
| 4mg | 90 pills | £0.92 | £83.17 | |
| 4mg | 60 pills | £1.12 | £67.43 | |
| 4mg | 30 pills | £1.32 | £39.33 |
Disclaimer: This information is for general guidance and does not replace personalised advice from a pharmacist or clinician. Seek professional guidance for specific questions about suitability, dosing, and monitoring.
What happens during an asthma flare or other breathing difficulty when air passages narrow and airflow is restricted?
Ventolin pills contain the active ingredient salbutamol (sal‑BYOO-tam ALL), a bronchodilator that opens the airways. Salbutamol belongs to a class of medicines known as short-acting beta-2 adrenergic agonists (SABAs), which relax airway smooth muscle to ease breathing.
The pill form is not the common presentation for Ventolin; inhaled forms are the standard delivery in routine use. If an oral tablet form is prescribed, it is intended to provide systemic bronchodilation with the same active ingredient through a different route of administration.
Prescribing rules and availability may vary by country and local regulations. The official patient information leaflet should be consulted, and a pharmacist or clinician should be contacted for individual guidance on the pill form and its proper use.
Ventolin pills are used to relieve bronchospasm, a sudden tightening of the airway muscles, in conditions such as asthma and certain chronic lung diseases (for example, chronic obstructive pulmonary disease, or COPD). The medicine acts quickly to reduce breathlessness during episodes.
Salbutamol’s effect is primarily to provide rapid relief of acute symptoms by widening the airways. It does not treat the underlying inflammation that drives many chronic airway conditions; anti-inflammatory therapies may be required as part of long-term management.
Temporary relief is the primary purpose of this medicine when used as prescribed. Caution is advised in certain situations, such as pregnancy or breastfeeding, and in the presence of other medical conditions or medications. Guidance from a clinician or pharmacist should be followed carefully.
All information about use, safety, and interactions should be cross-checked with the official leaflet supplied with the product. If uncertainty arises, the reader should consult a healthcare professional.
Step-by-step initiation helps ensure appropriate use and monitoring. The following steps provide a framework for starting therapy in line with professional guidance.
Verify whether the medication is to be used as an oral tablet and confirm the prescription requirements with the pharmacist. Some local rules may require a prescription; other arrangements may apply in different regions.
Check the product label and patient information leaflet for the exact active ingredient, strength, and any excipients that may affect tolerance or allergies. If an allergy or prior adverse reaction is known, inform the clinician before starting.
Acquire the medication from an authorised pharmacy under proper supervision. Store in a cool, dry place away from direct sunlight, and keep out of reach of children. Do not transfer to unlabelled containers or share with others.
Inspect the packaging for intact seals and expiry dates before first use. Do not use if the packaging is damaged or the tablet appears altered.
The first dose should be taken exactly as directed by the prescribing clinician or the information leaflet. Swallow the tablet with a full glass of water unless instructed otherwise. Do not crush or chew tablets unless explicitly advised by a clinician, as crushing can alter the release profile or increase side effects.
In the event of any contraindication or intolerance, contact a clinician promptly. If new or unusual symptoms develop after the first dose, seek advice from a pharmacist or doctor.
Initial monitoring is often advised to assess response and tolerability. A routine follow-up appointment or contact with a pharmacist should be scheduled as advised by the prescriber. Any signs of worsening breathing, chest pain, or persistent adverse effects warrant immediate medical contact.
In cases of uncertain response or delayed improvement, the plan should be reviewed with a clinician. Do not adjust the dose or frequency without professional guidance.
Daily use should be directed by a clinician and tailored to the individual’s symptoms and medical history. The following guidance outlines practical aspects of daily management.
Oral formulations may have different timing or food-related instructions compared with inhaled forms. Whenever possible, follow the specific dosing schedule provided by the prescriber or the patient information leaflet. Do not alter timing without consultation.
In general, consider whether the medication is intended for as-needed relief of symptoms or for scheduled daily control. If used as-needed, administer only when symptoms begin to appear. If prescribed as part of a daily regimen, maintain consistency and avoid missed doses when possible—discuss any barriers to adherence with a clinician.
When meals are involved, determine whether food affects absorption or tolerance for the specific tablet; if so, take the medication with or without meals as instructed. If a dose is missed, consult the leaflet or contact a pharmacist for guidance; do not double up on a dose without professional advice.
During the initial days, a noticeable improvement in breathing may occur after taking the medication, depending on the individual and the form used. Response time and magnitude can vary between people and conditions.
Some individuals may experience side effects such as tremor, a rapid heartbeat, or headaches; these are typically transient. If adverse effects persist or worsen, a clinician should be informed promptly.
A consistent treatment plan, including any additional controller therapies, should be reviewed regularly to ensure alignment with symptom control goals. The medication is not intended to replace long-term anti-inflammatory strategies when those are indicated.
Early follow-up with a clinician or pharmacist is advised to confirm the intended effect and to adjust the plan if necessary. Any new medical conditions or changes in concomitant medications should be disclosed during follow-up.
Seek medical advice if breathing does not improve after using the medication as prescribed, or if new or worsening symptoms appear. Chest pain, fainting, severe palpitations, or signs of an allergic reaction require urgent assessment by a healthcare professional.
Other warning signs include significant dizziness, swelling, persistent tremors, or any new medication intolerances. If any such concerns arise, contact a clinician or a local NHS service for guidance.
Inform all treating clinicians about Ventolin pills use, especially when undergoing dental work, surgery, or starting new medicines. Drug interactions and device-specific instructions may be relevant to the safety and effectiveness of therapy.
Regular reviews are recommended to reassess the need for continuing the medication, adjust dosing as needed, and monitor for potential interactions with other prescriptions or over-the-counter products.
Keep Ventolin pills in their original packaging until ready to use. Store in a cool, dry place away from heat and moisture. Avoid exposing the tablets to excessive humidity or direct light, which can alter potency.
Keep out of reach of children and pets. Do not share medication with others, and do not use another person’s prescription even if symptoms seem similar.
Check the expiry date before each use. Do not use the product after the expiry date has passed. If there is any sign of tampering or compromised packaging, obtain a replacement from a pharmacy.
When travelling, carry the medication in its original container and follow local rules regarding medication in transit. If flying, ensure the medication is readily accessible in hand luggage where allowed by security guidelines. Seek advice from a pharmacist if any special handling is required during travel.
Absolute contraindications include any known hypersensitivity to salbutamol or to any excipients in the tablet formulation. A clinician should be consulted before initiating therapy in the presence of previous severe allergic reactions.
Caution is advised in individuals with significant heart conditions, tachyarrhythmias, severe hypertension, or uncorrected hypokalaemia. The potential for cardiovascular effects warrants close monitoring, especially after initiating therapy or when changing dose or formulation.
Beta-blocker medications can interfere with beta-adrenergic agonists and may diminish the effect of Ventolin pills. Inform a clinician about all prescribed medicines, including over‑the‑counter products and herbal supplements.
Pregnancy and breastfeeding require careful risk-benefit assessment. If pregnancy is planned or suspected, or if breastfeeding, consult a clinician before continuing therapy to determine the safest plan.
Carry the medication as advised, especially during periods of increased respiratory symptoms or exercise. Provide a brief explanation to a companion or travel partner about what to do if symptoms worsen.
When participating in sports or physical activity, follow the clinician’s guidance on the use of medication around activity. Consider whether an inhaled device or pill formulation is most suitable in the activity setting, and note any device-specific considerations.
Allergies, infections, or changes in health status may alter the therapeutic needs. Any new or worsening symptoms should prompt a review with a pharmacist or clinician to ensure continued safety and effectiveness.
Dental or dental anesthesia procedures may require notification of healthcare providers about Ventolin pills use to ensure safe management of potential interactions with local anesthetics or other agents. Reconcile any concerns with the clinician beforehand.
The following questions address common real‑world situations. Answers are cautious and avoid prescribing details such as exact dosing. When in doubt, consult the official leaflet or a healthcare professional.
Note: The following entries are not a substitute for professional guidance and are provided for general information.
Traveling with medications is common, but local regulations may vary. Carry the medication in its original packaging, with dosing instructions, and bring enough supply for the trip plus a small extra in case of delays. Check airline and customs rules in advance.
Taking a dose outside the prescribed timing may affect the intended control of symptoms or increase the risk of side effects. Do not alter timing without consultation. If an accidental late dose occurs, seek guidance from a pharmacist or clinician for safe next steps.
Potential interactions exist with some OTC products, including certain decongestants or stimulants. Inform a clinician about all medicines being used, including non-prescription products. Do not start new OTC therapies without professional advice.
Splitting or crushing tablets can alter absorption and effect. Only modify the preparation if instructed by a clinician. Otherwise, take tablets whole with water as directed.
Switching from a different bronchodilator requires medical supervision to adjust therapy safely. A clinician will consider the new medicine, potential interactions, and the overall management plan.
Onset time varies by formulation and individual factors. In many cases, improvement can be noticed within minutes to hours after taking the first dose, though full benefit may require ongoing use and adherence to the treatment plan.
Pre-exercise use may be advised in some individuals who experience exercise-induced bronchoconstriction. This should be done strictly under the guidance of a clinician, with attention paid to timing and potential side effects.
Inform the dentist about Ventolin pills use, as this can influence anesthesia choices and monitoring. The clinician can provide specific advice based on the planned procedures and other medications.
Safety in pregnancy should be discussed with a clinician. Some cases may benefit from continued therapy while others may require alternatives. A risk‑benefit assessment will guide the plan.
Dose adjustments should only be made under professional supervision. Self-adjustment without guidance may lead to inadequate control or adverse effects.
Maintain the medication in a stable environment as advised by the leaflet. For hospital stays, healthcare teams will coordinate storage and administration according to local practice and patient safety norms.
Persistent symptoms warrant medical review. A clinician may reassess the treatment plan, consider alternative therapies, or investigate other underlying causes of breathlessness.
Seek urgent medical help if signs of a severe reaction appear, such as chest pain, severe dizziness, swelling of the face or throat, or persistent trouble breathing beyond the expected response.
14–21 days. Free from £149.87 .
5–9 days. £22.48
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
